In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cempra Inc. (NASDAQ:CEMP) reported that 1globe Capital Llc. has picked up 944,201 of common stock as of 2017-06-13.
The acquisition brings the aggregate amount owned by 1globe Capital Llc. to a total of 944,201 representing 1.8% stake in the company.
For those not familiar with the company, Cempra, Inc. is a clinical-stage pharmaceutical company. The Company focuses on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases. Its product, solithromycin (CEM-101), which is a macrolide and fluoroketolide, is being developed in oral capsules, intravenous (IV) and suspension formulations for the treatment of community-acquired bacterial pneumonia (CABP). Solithromycin has therapeutic potential and activity to target pathogenic bacteria. It has completed two pivotal Phase III trials for solithromycin to treat CABP, as of December 31, 2016. Its Fusidic acid is an antibiotic and the Company is exploring its use for the long-term oral treatment for refractory bone and joint infections (BJI), including prosthetic joint infections, which are caused by staphylococci, including S. aureus, methicillin-resistant S. aureus, coagulase negative staphylococci and other gram-positive bacteria.
A glance at Cempra Inc. (NASDAQ:CEMP)’s key stats reveals a current market capitalization of 198.25 Million based on 52.45 Million shares outstanding and a price at last close of $3.83 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-01-03, Gill picked up 5,000 at a purchase price of $2.94. This brings their total holding to 5,000 as of the date of the filing.
On the sell side, the most recent transaction saw Goldstein unload 99,900 shares at a sale price of $3.57. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cempra Inc. (NASDAQ:CEMP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.